Author:
Badawi Rehab,Abu Rahma Mohamed Zakaria,Ramadan Haidi K.,Soliman Shaimaa,Mohareb Dina A.,Hawash Nehad,Elkafoury Rania,Abd-Elsalam Sherief
Abstract
Background
Liver cirrhosis is a diffuse process in which the anatomical structure and function of the liver are disturbed. Lipid metabolism occurs mainly in the hepatocytes. In liver cirrhosis, it is expected to detect abnormal lipid profile and abnormal neutrophil to lymphocyte ratio due to necro-inflammation and hepatocyte dysfunction. This study aimed to estimate the lipid profile in patients with liver cirrhosis and to assess its relation to the severity of the liver disease based on Child-Pugh Turcotte score and Neutrophil to Lymphocyte Ratio (NLR).
Methods:
This study included 500 cirrhotic patients. All patients are subjected to history taking, clinical examination, liver and renal function tests, lipid profile, and also abdomino-pelvic ultrasound. Child -Pugh score, fibrosis-4 score (FIB4), and neutrophil and platelet lymphocyte ratio were calculated.
Results:
A total of 500 patients were enrolled in this study; 12 patients were excluded (two patients were on the immunosuppressive drug, three patients had body mass index (BMI) >30, and seven patients took lipid-lowering drugs). Cholesterol level was significantly higher in patients with Child- Score A than B and C. Cholesterol, Low-Density Lipoprotein (LDL), and very-low-density lipoprotein (VLDL) cholesterol were significantly higher in Child B than C. A significant negative correlation was found between cholesterol level and each of FIB4 and NLR ratios.
Conclusion:
There was a significant negative correlation between the severity of liver cirrhosis and lipid profiles (except triglyceride), FIB4 and NLR ratio.
Publisher
Bentham Science Publishers Ltd.
Subject
Biochemistry (medical),Clinical Biochemistry,Medicine (miscellaneous)
Reference33 articles.
1. Anthony PP, Ishak KG, Nayak NC, Poulsen HE, Scheuer PJ, Sobin LH.
The morphology of cirrhosis. Recommendations on definition, nomenclature, and classification by a working group sponsored by the World Health Organization.
J Clin Pathol
1978;
31
(5)
: 395-414.
2. Elgouhari HM, Abu-Rajab Tamimi TI, Carey WD.
Hepatitis B virus infection: understanding its epidemiology, course, and diagnosis.
Cleve Clin J Med
2008;
75
(12)
: 881-9.
3. Kwon YC, Ray RB, Ray R.
Hepatitis C virus infection: establishment of chronicity and liver disease progression.
EXCLI J
2014;
13
: 977-96.
4. Council G, Assembly G.
Global burden of liver disease: A true burden on health sciences and economies.
Available from:
http://www.worldgastroenterology.org/ publications/ e-wgn/ e-wgn-expert-point-of-view-articles-collection/global-burden-of-liver-disease-a-true-burden-on-health-sciences-and-economies
5. Aguiar MI, Braga VA, Almeida PC, Garcia JH, Lima CA.
Severity of liver disease and quality of life in liver transplantation.
Acta Paul Enferm
2016;
29
(1)
: 107-14.